These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 28260044)

  • 1. microRNA-125b reverses the multidrug resistance of nasopharyngeal carcinoma cells via targeting of Bcl-2.
    Yuan TZ; Zhang HH; Lin XL; Yu JX; Yang QX; Liang Y; Deng J; Huang LJ; Zhang XP
    Mol Med Rep; 2017 Apr; 15(4):2223-2228. PubMed ID: 28260044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Has‑miR‑125a and 125b are induced by treatment with cisplatin in nasopharyngeal carcinoma and inhibit apoptosis in a p53‑dependent manner by targeting p53 mRNA.
    Chen JJ; Liu SX; Chen MZ; Zhao ZY
    Mol Med Rep; 2015 Sep; 12(3):3569-3574. PubMed ID: 26017674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-132 sensitizes nasopharyngeal carcinoma cells to cisplatin through regulation of forkhead box A1 protein.
    Li YL; Zhao YG; Chen B; Li XF
    Pharmazie; 2016 Dec; 71(12):715-718. PubMed ID: 29442000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-139-5p affects cisplatin sensitivity in human nasopharyngeal carcinoma cells by regulating the epithelial-to-mesenchymal transition.
    Shao Q; Zhang P; Ma Y; Lu Z; Meng J; Li H; Wang X; Chen D; Zhang M; Han Y; Liu H; Ma S
    Gene; 2018 Apr; 652():48-58. PubMed ID: 29427737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Autophagy Potentiated the Antitumor Effect of Nedaplatin in Cisplatin-Resistant Nasopharyngeal Carcinoma Cells.
    Liu Z; Liu J; Li L; Nie D; Tao Q; Wu J; Fan J; Lin C; Zhao S; Ju D
    PLoS One; 2015; 10(8):e0135236. PubMed ID: 26288183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversing effect of sorcin in the drug resistance of human nasopharyngeal carcinoma.
    Liu X; Chen L; Feng B; Liu G
    Anat Rec (Hoboken); 2014 Feb; 297(2):215-21. PubMed ID: 24376145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.
    Wang G; Wang S; Li C
    Tumour Biol; 2017 Jun; 39(6):1010428317703825. PubMed ID: 28631568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification Keratin 1 as a cDDP-resistant protein in nasopharyngeal carcinoma cell lines.
    Tang S; Huang W; Zhong M; Yin L; Jiang H; Hou S; Gan P; Yuan Y
    J Proteomics; 2012 Apr; 75(8):2352-60. PubMed ID: 22348822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
    Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
    Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.
    Lin FJ; Lin XD; Xu LY; Zhu SQ
    Mol Cells; 2020 Oct; 43(10):856-869. PubMed ID: 33115978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of GRP78 enhances cell death by cisplatin and radiotherapy in nasopharyngeal cells.
    Huang YY; Pu LJ; Song LL; Ma LY; Liu H; Jiang CC
    Anticancer Drugs; 2016 Sep; 27(8):726-33. PubMed ID: 27254284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-29c enhances the sensitivities of human nasopharyngeal carcinoma to cisplatin-based chemotherapy and radiotherapy.
    Zhang JX; Qian D; Wang FW; Liao DZ; Wei JH; Tong ZT; Fu J; Huang XX; Liao YJ; Deng HX; Zeng YX; Xie D; Mai SJ
    Cancer Lett; 2013 Feb; 329(1):91-8. PubMed ID: 23142283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-1278 sensitizes nasopharyngeal carcinoma cells to cisplatin and suppresses autophagy via targeting ATG2B.
    Zhao Y; Wang P; Wu Q
    Mol Cell Probes; 2020 Oct; 53():101597. PubMed ID: 32407879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of sorafenib and sunitinib in the induction of expressions of NKG2D ligands in nasopharyngeal carcinoma with high expression of ABCG2.
    Huang Y; Wang Y; Li Y; Guo K; He Y
    J Cancer Res Clin Oncol; 2011 May; 137(5):829-37. PubMed ID: 20809412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FBW7 increases drug sensitivity to cisplatin in human nasopharyngeal carcinoma by downregulating the expression of multidrug resistance-associated protein.
    Song Y; Zhou X; Bai W; Ma X
    Tumour Biol; 2015 Jun; 36(6):4197-202. PubMed ID: 25586348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Positive regulation of ataxia-telangiectasia-mutated protein (ATM) by E2F transcription Factor 1 (E2F-1) in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhou ZY; Yang JY; Shao CZ; Luo F; Du W
    World J Surg Oncol; 2022 Mar; 20(1):88. PubMed ID: 35303867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect and mechanism of microRNA-21 on cis-dichlorodiamineplatinum resistance in lung cancer cell strain].
    Ren L; Huang C; Liu YH; Yu Y; Lin L; Wen LJ
    Zhonghua Yi Xue Za Zhi; 2016 May; 96(18):1454-8. PubMed ID: 27266356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial-mesenchymal transition is necessary for acquired resistance to cisplatin and increases the metastatic potential of nasopharyngeal carcinoma cells.
    Zhang P; Liu H; Xia F; Zhang QW; Zhang YY; Zhao Q; Chao ZH; Jiang ZW; Jiang CC
    Int J Mol Med; 2014 Jan; 33(1):151-9. PubMed ID: 24173500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-31 regulates the cisplatin resistance by targeting Src in gallbladder cancer.
    Li M; Chen W; Zhang H; Zhang Y; Ke F; Wu X; Zhang Y; Weng M; Liu Y; Gong W
    Oncotarget; 2016 Dec; 7(50):83060-83070. PubMed ID: 27825112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combination of cytosine arabinoside and cisplatin enhances inhibition of cell proliferation and promotes apoptosis of resistant nasopharyngeal carcinoma cells].
    Chen J; Liu S; Li Q; Peng J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Mar; 31(3):379-82, 386. PubMed ID: 25744845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.